Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$6.55 USD
-0.44 (-6.29%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.60 +0.05 (0.76%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
12/09/2024
Time: -- |
9/2024 | $0.32 | 0.00% |
Earnings Summary
For their last quarter, Emergent Biosolutions (EBS) reported earnings of -$2.32 per share, missing the Zacks Consensus Estimate of -$0.97 per share. This reflects a negative earnings surprise of 139.18%. Look out for EBS's next earnings release expected on December 09, 2024. For the next earning release, we expect the company to report earnings of $0.32 per share, reflecting a year-over-year increase of 122.22%.
Earnings History
Price & Consensus
Zacks News for EBS
EBS Stock Rises on FDA Nod for ACAM2000 in Mpox Indication
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services